Specifically, NFE2L2, NLRP3, ATP7A, FDX1, LIAS, LIPT1, LIPT2, DLD, MTF1, GLS, DBT, GCSH, and DLST were higher expressed in normal tissues compared with tumor samples, while CDKN2A, SLC31A1, ATP7B, and PDHB were higher expressed in breast cancer tissues (Table 1). This evidence concerns the gene CDKN2A and breast carcinoma.